Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119498) titled 'Clinical Study on the Enhanced Antitumor Effect of Fecal Microbiota Transplantation Combined with Chemotherapy in Gastrointestinal Tumors: Exploration of the Mechanism of Synergy and Translational Pathways' on Feb. 28.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Tianjin Third Central Hospital
Condition:
Digestive tract tumors require treatment by the oncology department, which may include chemotherapy, targeted therapy or immunotherapy.
Intervention:
Standard Oncology Treatment Group
Standard Oncology Treatment Combined with FMT Group:FMT
Recruitment Status: Not Recruiting
...